142 related articles for article (PubMed ID: 12379777)
21. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
22. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
[TBL] [Abstract][Full Text] [Related]
23. Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.
Renner M; Wolf T; Meyer H; Hartmann W; Penzel R; Ulrich A; Lehner B; Hovestadt V; Czwan E; Egerer G; Schmitt T; Alldinger I; Renker EK; Ehemann V; Eils R; Wardelmann E; Büttner R; Lichter P; Brors B; Schirmacher P; Mechtersheimer G
Genome Biol; 2013 Dec; 14(12):r137. PubMed ID: 24345474
[TBL] [Abstract][Full Text] [Related]
24. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.
Justice RW; Zilian O; Woods DF; Noll M; Bryant PJ
Genes Dev; 1995 Mar; 9(5):534-46. PubMed ID: 7698644
[TBL] [Abstract][Full Text] [Related]
25. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
[TBL] [Abstract][Full Text] [Related]
26. Make WARTS, not cancer!
Edwards KM; Münger K
Oncogene; 2004 Jul; 23(31):5263-5. PubMed ID: 15122320
[TBL] [Abstract][Full Text] [Related]
27. Human LATS1 is a mitotic exit network kinase.
Bothos J; Tuttle RL; Ottey M; Luca FC; Halazonetis TD
Cancer Res; 2005 Aug; 65(15):6568-75. PubMed ID: 16061636
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
29. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
Orlow I; Drobnjak M; Zhang ZF; Lewis J; Woodruff JM; Brennan MF; Cordon-Cardo C
J Natl Cancer Inst; 1999 Jan; 91(1):73-9. PubMed ID: 9890173
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.
Yu T; Bachman J; Lai ZC
Genetics; 2013 Nov; 195(3):1193-6. PubMed ID: 24026096
[TBL] [Abstract][Full Text] [Related]
31. DNA hypermethylation status of multiple genes in soft tissue sarcomas.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Takahira T; Kobayashi C; Tamiya S; Tateishi N; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 Jan; 19(1):106-14. PubMed ID: 16258501
[TBL] [Abstract][Full Text] [Related]
32. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
Yoo J; Robinson RA
Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
[TBL] [Abstract][Full Text] [Related]
33. Detection of TP53 gene mutations in human sarcomas.
Castresana JS; Rubio MP; Gómez L; Kreicbergs A; Zetterberg A; Barrios C
Eur J Cancer; 1995; 31A(5):735-8. PubMed ID: 7640047
[TBL] [Abstract][Full Text] [Related]
34. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
35. Alterations of the p15, p16,and p18 genes in osteosarcoma.
Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
[TBL] [Abstract][Full Text] [Related]
36. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function.
Iida S; Hirota T; Morisaki T; Marumoto T; Hara T; Kuninaka S; Honda S; Kosai K; Kawasuji M; Pallas DC; Saya H
Oncogene; 2004 Jul; 23(31):5266-74. PubMed ID: 15122335
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of PIK3CA, JAK2, BRAF, FOXL2, IDH1, AKT1 and EZH2 oncogenes in sarcomas.
Je EM; An CH; Yoo NJ; Lee SH
APMIS; 2012 Aug; 120(8):635-9. PubMed ID: 22779686
[TBL] [Abstract][Full Text] [Related]
40. Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis.
Yang X; Li DM; Chen W; Xu T
Oncogene; 2001 Oct; 20(45):6516-23. PubMed ID: 11641775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
